GO:0008157 protein phosphatase 1 binding: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0008157 (protein phosphatase 1 binding) is a molecular function describing the selective interaction of a protein with protein phosphatase 1 (PP1).
• PP1 is a major serine/threonine phosphatase whose specificity is dictated by hundreds of regulatory subunits and inhibitor proteins that bind the catalytic core.
• Binding partners such as Inhibitor-2, PNUTS, Repo-Man, ASPPs and FILIP1 control PP1 localization, substrate targeting and activity in processes from mitosis to synaptic plasticity [2,4,5,8].
• Dysregulated PP1 binding contributes to cancer, chromosomal instability, neurodegeneration and muscle disease [4,5,7].
• CRISPR knockout, point mutation, knock-in and overexpression models are essential to test whether a candidate PP1-binding protein is causally involved in a phenotype [1,4].
• EDITGENE provides end-to-end CRISPR cell model and library screening services to dissect PP1-binding networks at scale.
Description
Protein phosphatase 1 (PP1) is one of the most abundant serine/threonine phosphatases in eukaryotic cells and controls a vast array of signaling events by reversing phosphorylation on hundreds of substrates. Because the PP1 catalytic subunit has little intrinsic substrate specificity, its biological functions depend on a large family of PP1-interacting proteins that bind the catalytic core and direct it to specific substrates, compartments and regulatory inputs. The Gene Ontology molecular function term GO:0008157, protein phosphatase 1 binding, captures this essential interaction: the selective, non-covalent association of a protein with PP1. Researchers study GO:0008157 because PP1-binding proteins act as the decision-making layer of PP1 signaling. For example, Inhibitor-2 binds and inhibits PP1 while also acting as a chaperone for its folding, illustrating the dual regulatory logic of PP1 binders. Other binders, such as PNUTS, Repo-Man and the ASPP family, recruit PP1 to chromatin, the nuclear envelope or specific substrates to control mitosis, gene expression and cell survival [1,4,8]. Disruption of these interactions has been linked to chromosomal instability, cancer and neurological disorders [4,7]. This article summarizes the definition, mechanism, key genes and experimental approaches for GO:0008157, with a focus on how CRISPR-based models and functional genomics can be used to interrogate PP1-binding networks in health and disease [1,4,5].
protein phosphatase 1 binding At A Glance
| GO ID | GO:0008157 |
|---|---|
| GO term | protein phosphatase 1 binding |
| Ontology | molecular_function |
| Synonym | none |
| Major function | Selective binding to protein phosphatase 1 (PP1), enabling targeting, regulation or inhibition of PP1 activity [1,2]. |
| Representative binders | Inhibitor-2, PNUTS, Repo-Man, ASPP1/2, FILIP1, among many others [1,2,4,5,8]. |
| Biological context | Cell cycle control, chromatin regulation, synaptic plasticity, muscle mechanics and nuclear events [3,4,5,7,8]. |
| Disease relevance | Cancer, chromosomal instability, neurodegeneration and muscle disease [4,5,7]. |
| Research methods | CRISPR KO/point mutation/knock-in/overexpression, co-immunoprecipitation, phosphatase assays, imaging [1,4,5,6]. |
What Is GO:0008157?
GO:0008157 protein phosphatase 1 binding is defined by QuickGO as the binding to a protein phosphatase 1. In practical terms, it describes any protein that physically and selectively interacts with the PP1 catalytic subunit or its holoenzyme complexes, typically through short linear motifs such as the RVxF motif, and thereby modulates PP1 localization, substrate selection or catalytic activity [1,2].
Why Is protein phosphatase 1 binding Important in Cell Biology?
GO:0008157 is important because PP1 is a central phosphatase in eukaryotic signaling, and its binding partners determine when, where and on which substrates PP1 acts. Without these interactions, PP1 cannot achieve the specificity required for processes such as mitotic exit, synaptic remodeling, nuclear organization and mechanical stress responses [3,4,5,7,8]. Consequently, mutations or expression changes in PP1-binding proteins can rewire phosphorylation networks and drive disease, making this term a focal point for both mechanistic cell biology and therapeutic target discovery [4,5,7].
• Defines the targeting code that gives PP1 its substrate specificity.
• Controls cell cycle progression and chromosome segregation through binders such as PNUTS and Repo-Man [4,8].
• Regulates synaptic structure and plasticity via PP1 interactions in dendritic spines.
• Modulates nuclear events including transcription, chromatin remodeling and nuclear envelope dynamics [7,8].
• Participates in muscle mechanotransduction through FILIP1 and filamin C regulation.
• Provides a druggable interface for chemical disruptors and photoactivatable peptides.
• Links to cancer through ASPP family and PNUTS-mediated pathways [1,4].
• Offers a rich source of candidate genes for CRISPR functional screens [1,4].
• Enables quantitative studies of phosphorylation dynamics using phosphatase assays and phosphoproteomics [2,5].
• Supports development of targeted therapies that modulate PP1 holoenzyme composition.
What Happens During protein phosphatase 1 binding?
Recognition and docking of PP1-binding motifs
In simple terms: Proteins that bind PP1 usually carry a short docking motif that fits into a groove on PP1.
Most PP1 interactors contain a canonical RVxF motif that docks into a hydrophobic channel on the PP1 catalytic subunit, allowing stable but reversible binding. Additional motifs, such as the SILK and MyPhoNE motifs, can further stabilize or modulate the interaction, creating a combinatorial code for PP1 recognition. This docking step is the first committed event in GO:0008157 and determines which proteins can compete for PP1 in a given cell state.
Formation of PP1 holoenzyme complexes
In simple terms: Once bound, the partner protein becomes part of a larger PP1 machine that can act on specific targets.
Binding of regulatory subunits converts the PP1 catalytic subunit into a holoenzyme with defined substrate specificity and subcellular localization. For example, PNUTS binds PP1 to form a complex that prevents CENP-A mislocalization and chromosomal instability. Similarly, Repo-Man recruits PP1 to chromatin and the nuclear envelope, where SUMOylation of Repo-Man modulates binding to lamin A and dephosphorylation of serine 22. These complexes illustrate how GO:0008157 enables spatial and temporal control of phosphatase activity [4,8].
Substrate targeting and catalytic activation
In simple terms: The bound partner positions PP1 next to its target so it can remove phosphate groups efficiently.
After docking, the PP1 holoenzyme is guided to specific substrates through additional interaction surfaces on the regulatory subunit. In skeletal muscle cells under mechanical stress, PP1 regulates the binding of filamin C to FILIP1, thereby controlling cytoskeletal remodeling. In dendritic spines, PP1 binding partners modulate actin dynamics and receptor trafficking, influencing synaptic strength. Thus, GO:0008157 directly couples PP1 binding to substrate dephosphorylation and downstream cellular responses [3,5].
Inhibition and chaperone functions
In simple terms: Some PP1 binders block its activity or help it fold correctly.
Inhibitor-2 is a dual-function PP1 binder that can inhibit phosphatase activity while also acting as a chaperone for PP1 folding and maturation. This dual activity regulation highlights that GO:0008157 encompasses not only targeting but also negative regulation and quality control of PP1. Small molecules and peptides that disrupt such interactions, such as photoactivatable PP1-disrupting peptides, can be used to probe these functions experimentally.
Dynamic exchange and multimerization
In simple terms: PP1 partners can exchange and even cluster together to fine-tune signaling.
Recent work shows that ASPP family proteins can multimerize PP1, forming higher-order assemblies that may influence phosphatase output. This multimerization adds another layer of regulation to GO:0008157, suggesting that binding is not always a simple one-to-one event but can involve cooperative assemblies. Dynamic exchange of partners allows cells to rapidly rewire PP1 signaling in response to stimuli [1,2].
Key Genes Involved in GO:0008157 protein phosphatase 1 binding
The following genes and proteins represent well-documented PP1-binding partners and regulators that are frequently studied in the context of GO:0008157.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PPP1CA | Catalytic subunit of PP1 alpha | Core phosphatase targeted by GO:0008157 binders. |
| PPP1CB | Catalytic subunit of PP1 beta | Alternative PP1 isoform with distinct binding preferences. |
| PPP1CC | Catalytic subunit of PP1 gamma | Isoform involved in cell cycle and nuclear functions. |
| PPP1R2 | Inhibitor-2, dual regulator and chaperone | Model for inhibition and folding of PP1. |
| PPP1R10 | PNUTS, chromatin-associated PP1 regulator | Prevents CENP-A mislocalization and chromosomal instability. |
| PPP1R12A | MYPT1, myosin phosphatase targeting subunit | Regulates smooth muscle contraction and cytoskeleton. |
| PPP1R15A | GADD34, stress-induced PP1 regulator | Links PP1 to integrated stress response. |
| PPP1R15B | CREP, constitutive PP1 regulator | Controls translation and stress recovery. |
| PPP1R3A | Muscle-specific glycogen targeting subunit | Regulates glycogen metabolism. |
| PPP1R9A | Neurabin-1, synaptic PP1 binder | Modulates dendritic spine morphology. |
| PPP1R9B | Neurabin-2/spinophilin, synaptic PP1 binder | Regulates synaptic plasticity. |
| ASPP1 | Ankyrin-repeat PP1-binding protein | Multimerizes PP1 and affects cell survival. |
| ASPP2 | Ankyrin-repeat PP1-binding protein | Multimerizes PP1 and affects cell survival. |
| FILIP1 | Filamin A interacting protein 1 | Mediates PP1-dependent filamin C binding in muscle. |
| FLNC | Filamin C, actin-crosslinking protein | Substrate of PP1-regulated binding to FILIP1. |
| REPO-MAN | Nuclear envelope PP1 recruiter | SUMOylation-dependent binding to lamin A. |
| LMNA | Lamin A/C, nuclear envelope protein | Dephosphorylated by Repo-Man-PP1 complex. |
How Is protein phosphatase 1 binding Regulated?
GO:0008157 is regulated at multiple levels. The expression and post-translational modification of PP1-binding proteins, such as SUMOylation of Repo-Man, can alter their affinity for PP1 and their subcellular localization. Inhibitor-2 provides dual regulation by inhibiting PP1 activity while promoting its proper folding. Mechanical stress in muscle cells can change the interaction between PP1, filamin C and FILIP1, demonstrating that binding is responsive to physical cues. In neurons, synaptic activity modulates PP1 binding to neurabins and other partners, thereby affecting dendritic spine dynamics. Additionally, multimerization of ASPP proteins can create cooperative binding platforms that may amplify or diversify PP1 signaling. Together, these mechanisms ensure that PP1 binding is dynamic and context-dependent [1,2,3,5,8].
protein phosphatase 1 binding and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PPP1R10 (PNUTS) | Chromosomal instability, cancer | CRISPR knockout in cancer cell lines, followed by karyotyping and CENP-A imaging. |
| ASPP1/ASPP2 | Cancer, apoptosis regulation | Knockout and overexpression models to study PP1 multimerization and cell survival. |
| FLNC | Myopathy, muscle disease | Point mutation knock-in in muscle cells to test PP1-dependent filamin C binding. |
| LMNA | Laminopathies, nuclear envelope disorders | Knock-in of phospho-mutant lamin A to study Repo-Man-PP1 binding. |
| PPP1R9B (spinophilin) | Neurodegeneration, synaptic dysfunction | Knockout mice or neurons to assess dendritic spine changes. |
Cancer and chromosomal instability
Dysregulation of PP1-binding proteins is linked to cancer. PNUTS (PPP1R10) prevents CENP-A mislocalization, and its loss leads to chromosomal instability, a hallmark of tumorigenesis. ASPP family proteins, which bind and multimerize PP1, are known regulators of apoptosis and cell survival, and their altered function can contribute to cancer progression. These findings position GO:0008157 as a relevant axis in cancer biology [1,4].
Neurodegeneration and synaptic dysfunction
PP1 binding partners such as neurabins and spinophilin regulate dendritic spine morphology and synaptic plasticity. Disruption of these interactions has been implicated in cognitive disorders and neurodegeneration, where aberrant phosphatase activity contributes to synaptic loss. The nuclear roles of PP1, including chromatin regulation, may also impact neuronal gene expression and survival.
Muscle disease and mechanotransduction
In skeletal muscle, PP1 regulates the binding of filamin C to FILIP1 under mechanical stress. Mutations in filamin C (FLNC) cause myopathies, and PP1-mediated dephosphorylation events are critical for maintaining cytoskeletal integrity. Thus, GO:0008157 is directly relevant to muscle disease mechanisms.
Nuclear envelope and laminopathies
Repo-Man recruits PP1 to dephosphorylate lamin A at serine 22, a process dependent on Repo-Man SUMOylation. Defects in this pathway can affect nuclear envelope dynamics and are relevant to laminopathies and nuclear organization diseases. This highlights the importance of PP1 binding in nuclear events [7,8].
From protein phosphatase 1 binding-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of a PP1-binding protein affect cell cycle progression? | CRISPR knockout of the candidate gene in HeLa or RPE1 cells, followed by live-cell imaging. |
| Does a specific phosphorylation site on a PP1 binder control its interaction with PP1? | Point mutation knock-in of phospho-null or phospho-mimetic residues [5,8]. |
| Can a PP1-binding protein be tagged for localization studies? | Knock-in of fluorescent or affinity tags at the endogenous locus. |
| Does overexpression of a PP1 binder alter phosphatase activity? | Doxycycline-inducible overexpression in mammalian cells, followed by phosphatase assays. |
| Which PP1-binding proteins are essential for synaptic plasticity? | CRISPR knockout in primary neurons or brain organoids, combined with electrophysiology. |
| Can chemical disruptors of PP1 binding be tested? | Photoactivatable peptide treatment in cells expressing PP1 biosensors. |
How to Study the protein phosphatase 1 binding Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Co-immunoprecipitation | Physical interaction between PP1 and candidate proteins | Identifying novel PP1 binders [1,2]. |
| Mass spectrometry | Protein composition of PP1 complexes | Mapping PP1 interactome. |
| Phosphatase assay | Catalytic activity of PP1 in presence of binders | Testing regulatory subunits [2,5]. |
| CRISPR knockout | Loss-of-function phenotype | Validating candidate PP1-binding genes. |
| Point mutation knock-in | Effect of specific residues on binding | Dissecting phospho-regulation [5,8]. |
| Fluorescence imaging | Subcellular localization and dynamics | Tracking PP1 complexes in live cells [3,8]. |
| Photoactivatable peptides | Acute disruption of PP1 binding | Probing immediate effects of binding loss. |
| Proximity labeling | Spatial interactome of PP1 | Identifying compartment-specific binders. |
Co-immunoprecipitation and mass spectrometry
Co-immunoprecipitation of PP1 followed by mass spectrometry is a standard approach to identify novel PP1-binding proteins and map interaction networks [1,2]. This method can be combined with quantitative proteomics to compare binding affinities across conditions.
Phosphatase activity assays
In vitro phosphatase assays using purified PP1 and candidate substrates measure the functional impact of binding partners on catalytic activity [2,5]. These assays can be adapted to high-throughput formats to screen for modulators of GO:0008157.
CRISPR-based functional genomics
CRISPR knockout, point mutation and knock-in models allow precise interrogation of PP1-binding protein function in cells [1,4]. Pooled CRISPR screens can identify genes that modify PP1-dependent phenotypes, such as chromosomal stability or drug sensitivity.
Advanced imaging and biosensors
Fluorescent biosensors and live-cell imaging can visualize PP1 binding dynamics in real time [3,8]. For example, tagging endogenous PP1 or its partners with fluorescent proteins enables tracking of complex formation at specific subcellular locations [1,8].
How CRISPR Can Be Used to Study GO:0008157 protein phosphatase 1 binding
Knockout
CRISPR knockout of genes encoding PP1-binding proteins is used to test loss-of-function phenotypes, such as chromosomal instability upon PNUTS deletion. Knockout cell lines provide clean backgrounds for rescue experiments and for assessing the contribution of specific binders to PP1-dependent processes.
Point Mutation
Point mutation knock-in can be used to ablate or mimic phosphorylation sites on PP1 binders, thereby testing how post-translational modifications control binding [5,8]. For example, mutating the SUMOylation site on Repo-Man affects its binding to lamin A and PP1-dependent dephosphorylation.
Knock-in
Knock-in of tags or reporters at endogenous loci allows visualization and biochemical isolation of PP1 complexes without overexpression artifacts. This approach is valuable for studying multimerization of ASPP proteins and their interaction with PP1.
Overexpression
Overexpression of wild-type or mutant PP1-binding proteins can reveal dominant effects on phosphatase activity and cellular phenotypes. Inducible systems are preferred to avoid adaptation and to control expression levels.
How EDITGENE Supports protein phosphatase 1 binding Research
Researchers studying protein phosphatase 1 binding-related genes often need to determine whether a candidate gene is causally involved in a phenotype, how specific residues contribute to PP1 interaction, and whether the interaction can be targeted therapeutically. EDITGENE provides the CRISPR tools and services to answer these questions with precision and scale.
Contact EDITGENE today to design your custom CRISPR model for protein phosphatase 1 binding research.
Frequently Asked Questions About protein phosphatase 1 binding
What is GO:0008157 protein phosphatase 1 binding?
GO:0008157 is a Gene Ontology molecular function term defined as binding to a protein phosphatase 1 (PP1). It describes proteins that physically interact with PP1 to regulate its localization, activity or substrate specificity [1,2].
What genes are involved in protein phosphatase 1 binding?
Key genes include PPP1CA, PPP1CB, PPP1CC (PP1 catalytic subunits), PPP1R2 (Inhibitor-2), PPP1R10 (PNUTS), PPP1R9A/B (neurabins), ASPP1/2, FILIP1 and REPO-MAN, among many others [1,2,3,4,5,8].
How does PP1 binding regulate cell division?
PP1-binding proteins such as PNUTS and Repo-Man recruit PP1 to chromatin and the nuclear envelope to control mitotic progression and chromosome segregation. Loss of these interactions can cause chromosomal instability [4,8].
What diseases are linked to protein phosphatase 1 binding?
Dysregulated PP1 binding has been implicated in cancer, chromosomal instability, neurodegeneration, muscle myopathies and laminopathies [1,3,4,5,7,8].
How can I study protein phosphatase 1 binding in the lab?
Common methods include co-immunoprecipitation, mass spectrometry, phosphatase assays, CRISPR knockout/knock-in, and live-cell imaging with fluorescent biosensors [1,2,3,4,5,6,8].
What is the role of Inhibitor-2 in PP1 binding?
Inhibitor-2 (PPP1R2) binds PP1 and acts as both an inhibitor of phosphatase activity and a chaperone for PP1 folding, illustrating dual regulation.
Can PP1 binding be targeted therapeutically?
Yes, photoactivatable PP1-disrupting peptides and small molecules that interfere with PP1-protein interactions are being developed as research tools and potential therapeutics.
What is the RVxF motif in PP1 binding?
The RVxF motif is a short linear sequence found in many PP1-binding proteins that docks into a hydrophobic groove on PP1, providing a primary binding interface.
How does mechanical stress affect PP1 binding in muscle?
In skeletal muscle cells, mechanical stress alters PP1-dependent regulation of filamin C binding to FILIP1, which is important for cytoskeletal remodeling.
What CRISPR models are available for studying PP1 binding?
CRISPR knockout, point mutation knock-in, tagged knock-in and overexpression models can all be used to dissect PP1-binding protein function. EDITGENE provides these services [1,4,5,6,8].
Conclusion
GO:0008157 protein phosphatase 1 binding is a fundamental molecular function that governs the specificity and regulation of one of the most important phosphatases in eukaryotic cells. Through a diverse set of binding partners, PP1 is directed to substrates involved in cell cycle control, synaptic plasticity, nuclear organization and muscle mechanics [2,3,4,5,7,8]. Disruption of these interactions contributes to cancer, neurodegeneration and muscle disease, making PP1-binding proteins attractive targets for functional genomics and therapeutic development [1,4,5,7]. CRISPR-based models, combined with biochemical and imaging approaches, provide powerful tools to dissect PP1-binding networks. EDITGENE offers comprehensive services to generate knockout, point mutation, knock-in and overexpression cell models, as well as library screening and bioinformatics support, enabling researchers to move from candidate gene to mechanistic insight efficiently [1,4,5,6].
References
- 1. Wei DT et al.. 2025. ASPPs multimerize protein phosphatase 1.. PLoS Genet 21(10):e1011731 PMID: 41100561
- 2. Lemaire S et al.. 2020. Protein phosphatase-1: dual activity regulation by Inhibitor-2.. Biochem Soc Trans 48(5):2229-2240 PMID: 33125485
- 3. Platholi J et al.. 2021. Modulation of dendritic spines by protein phosphatase-1.. Adv Pharmacol 90:117-144 PMID: 33706930
- 4. Balachandra V et al.. 2025. Protein Phosphatase 1 Regulatory Subunit PNUTS Prevents CENP-A Mislocalization and Chromosomal Instability.. Mol Cell Biol 45(5):185-197 PMID: 40270285
- 5. Kokot T et al.. 2024. Protein phosphatase-1 regulates the binding of filamin C to FILIP1 in cultured skeletal muscle cells under mechanical stress.. Sci Rep 14(1):27348 PMID: 39521905
- 6. Trebacz M et al.. 2020. Development of a Photoactivatable Protein Phosphatase-1-Disrupting Peptide.. J Org Chem 85(3):1712-1717 PMID: 31841001
- 7. Rebelo S et al.. 2015. Protein phosphatase 1 is a key player in nuclear events.. Cell Signal 27(12):2589-98 PMID: 26275498
- 8. Huguet F et al.. 2022. Repo-Man/protein phosphatase 1 SUMOylation mediates binding to lamin A and serine 22 dephosphorylation.. Open Biol 12(4):220017 PMID: 35414260
